SCHEMBL109443

SCHEMBL109443

C=CC(=O)NCCCCN

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.62
ZDHHC2 Q9UIJ5 1/20 0.62
PAOX Q6QHF9 2/20 0.52
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
DDAH1 O94760 1/20 0.44
TGM2 P21980 4/20 0.44
MAPT P10636 1/20 0.43
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
GAA P10253 1/20 0.41
SLC6A5 Q9Y345 2/20 0.40
GNAI3 P08754 1/20 0.39
GNAO1 P09471 1/20 0.39
GNAI1 P63096 1/20 0.39
CA12 O43570 1/20 0.37
F13A1 P00488 1/20 0.37
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976830 0.98 ZDHHC20 (0.66) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
SCHEMBL3686237 0.98 ZDHHC20 (0.66) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
Hydrochloric Acid SCHEMBL1286096 0.98 ZDHHC20 (0.60) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
SCHEMBL2631347 0.98 ZDHHC20 (0.66) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
Hydrochloric Acid SCHEMBL8983866 0.96 ZDHHC20 (0.63) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
SCHEMBL111105 0.93
SCHEMBL15271222 0.92 ZDHHC20 (0.55) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
SCHEMBL10524682 0.92 ZDHHC20 (0.59) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
Bromide SCHEMBL4449403 0.91 ZDHHC20 (0.57) ZDHHC20ZDHHC2PAOXTSHRALDH1A1
Iodide SCHEMBL4843404 0.91 ZDHHC20 (0.57) ZDHHC20ZDHHC2PAOXTSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137844-A1 MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME TERUMO KABUSHIKI KAISHA (JP) 2026-05-21 US claimed
EP-4740974-A1 MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR Terumo Kabushiki Kaisha (JP) 2026-05-13 EP claimed
US-12624275-B1 Temperature-resistant and salt-tolerant in-situ plugging enhanced gel compositions, gels, preparation methods and applications CHINA UNIVERSITY OF PETROLEUM-BEIJING (CN) 2026-05-12 US claimed
WO-2025260202-A1 AIR PRINTING OF HYDROGELS ALLARTA LIFE SCIENCE INC. (CA) 2025-12-26 WO claimed
WO-2025260203-A1 CLICK CHEMISTRY POLYMER HYDROGELS ALLARTA LIFE SCIENCE INC. (CA) 2025-12-26 WO claimed
WO-2025260204-A1 CROSSLINKED HYDROGELS WITH CONTROLLED PERMEABILITY ALLARTA LIFE SCIENCE INC. (CA) 2025-12-26 WO claimed
WO-2025050013-A1 COVALENT POLYMER-NUCLEIC ACID CONJUGATES FOR MODULATION OF THE RIG-I PATHWAY VANDERBILT UNIVERSITY (US) 2025-03-06 WO claimed
CN-105548302-B A kind of detection method to radical reaction 中国科学院烟台海岸带研究所 2018-05-25 CN claimed
CN-105548302-A Detecting method of free radical reaction YANTAI INST COASTAL ZONE RES CAS 2016-05-04 CN claimed
EP-3003413-A1 IMMOBILIZATION OF AN ACTIVE AGENT ON A SUBSTRATE USING COMPOUNDS INCLUDING TRIHYDROXYPHENYL GROUPS Baxter International Inc (US) 2016-04-13 EP claimed
CN-105377315-A IMMOBILIZATION OF AN ACTIVE AGENT ON A SUBSTRATE USING COMPOUNDS INCLUDING TRIHYDROXYPHENYL GROUPS BAXTER INT 2016-03-02 CN claimed
WO-2014197768-A1 IMMOBILIZATION OF AN ACTIVE AGENT ON A SUBSTRATE USING COMPOUNDS INCLUDING TRIHYDROXYPHENYL GROUPS BAXTER INTERNATIONAL INC. (US) 2014-12-11 WO claimed
CN-104105714-A Method of preparing acrylic polymers and products produced thereby LUBRIZOL ADVANCED MAT INC 2014-10-15 CN claimed
WO-2013019834-A1 DEGRADABLE SIX PACK RINGS AND COMPOSITIONS AND METHODS RELATING THERETO MYRIANT CORPORATION (US) 2013-02-07 WO claimed
EP-1593698-B1 The use and preparation of crosslinked polymer particles for inkjet recording materials HEWLETT PACKARD DEVELOPMENT CO (US) 2007-06-13 EP claimed
US-20260137844-A1 MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME TERUMO KABUSHIKI KAISHA (JP) 2026-05-21 US disclosed
EP-4740974-A1 MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR Terumo Kabushiki Kaisha (JP) 2026-05-13 EP disclosed
US-5547832-A AQUEOUS SOLUTIONS WHICH COMPRISE A FAST-ACTING HARDENER AND A POLYMERIC THICKENER EASTMAN KODAK COMPANY (US) 1996-08-20 US disclosed
EP-0578191-A2 Method and composition for hardening photographic materials EASTMAN KODAK COMPANY (US) 1994-01-12 EP disclosed
US-3959080-A Carrier matrix for the fixation of biochemically effective substances and process for the preparation thereof MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624275-B1 Temperature-resistant and salt-tolerant in-situ plugging enhanced gel compositions, gels, preparation methods and applications SAV1, MYD88, SMCHD1 ZDHHC20 4740/4885ZDHHC2 4539/4885PAOX 2673/4885
US-20260137844-A1 MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME F2, FGB, F9 ZDHHC20 2747/4885ZDHHC2 1578/4885PAOX 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.